These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors. Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495 [TBL] [Abstract][Full Text] [Related]
9. Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease? Barzilai A; Melamed E; Shirvan A Cell Mol Neurobiol; 2001 Jun; 21(3):215-35. PubMed ID: 11569535 [TBL] [Abstract][Full Text] [Related]
10. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040 [TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Yamada M; Oligino T; Mata M; Goss JR; Glorioso JC; Fink DJ Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4078-83. PubMed ID: 10097166 [TBL] [Abstract][Full Text] [Related]
13. Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition. Fornai F; Lenzi P; Gesi M; Ferrucci M; Lazzeri G; Busceti CL; Ruffoli R; Soldani P; Ruggieri S; Alessandri MG; Paparelli A J Neurosci; 2003 Oct; 23(26):8955-66. PubMed ID: 14523098 [TBL] [Abstract][Full Text] [Related]
14. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease. Offen D; Ziv I; Barzilai A; Gorodin S; Glater E; Hochman A; Melamed E Neurochem Int; 1997 Aug; 31(2):207-16. PubMed ID: 9220453 [TBL] [Abstract][Full Text] [Related]
16. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease. Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208 [TBL] [Abstract][Full Text] [Related]
17. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Tansey MG; McCoy MK; Frank-Cannon TC Exp Neurol; 2007 Nov; 208(1):1-25. PubMed ID: 17720159 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice. Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776 [TBL] [Abstract][Full Text] [Related]
19. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Yoo MS; Chun HS; Son JJ; DeGiorgio LA; Kim DJ; Peng C; Son JH Brain Res Mol Brain Res; 2003 Jan; 110(1):76-84. PubMed ID: 12573535 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis in Parkinson's disease: signals for neuronal degradation. Tatton WG; Chalmers-Redman R; Brown D; Tatton N Ann Neurol; 2003; 53 Suppl 3():S61-70; discussion S70-2. PubMed ID: 12666099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]